Publication | Open Access

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Tumor BiologyBreast OncologyEarly Breast CancerClinical RelapsesMedicineImmunologyPathologyBreast CancerCancer TreatmentOncologyRadiation OncologyCancer Research